• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及1型糖尿病患者肠道微生物群的研究。

Study of the gut microbiome in Egyptian patients with type 1 diabetes mellitus.

作者信息

Allakany Ahmed I, Elbanna Amany A, Rohoma Kamel H, Ahmed Shwikar M, Ibrahim Ahmed E, Fawzy Moamen A, Header Doaa A

机构信息

Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Department of Medical Microbiology and Immunology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

出版信息

Prz Gastroenterol. 2023;18(2):190-197. doi: 10.5114/pg.2023.126055. Epub 2023 Mar 22.

DOI:10.5114/pg.2023.126055
PMID:37538290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10395059/
Abstract

INTRODUCTION

Type 1 diabetes mellitus (T1DM) is an autoimmune disease. The gut microbiota has been proposed as a key actor in the pathogenesis of T1DM.

AIM

To identify the gut microbiome that are likely to be related to T1DM. This may have an impact on the future understanding of the pathogenesis of T1DM and possible approaches to prevent and treat it.

MATERIAL AND METHODS

The study included 40 T1DM patients and a cross-matching control group of 20 healthy subjects of matched age and sex; stool specimens were taken from each group. Quantitative SYBR Green Real-Time PCR technique targeting 16S rRNA was done for the identification and quantitation of , and .

RESULTS

T1DM patients showed significantly higher ( < 0.001) and ( = 0.003), but lower ( = 0.013) than the control group. However, there was no statistical difference between T1DM and control cases as regards ( = 0.204), ( = 0.598), ( = 0.901), and ( = 0.332).

CONCLUSIONS

Egyptian patients showed dysbiosis of the gut microbiome that can be related to the pathogenesis of T1DM. This hopefully points to the potential therapeutic benefits of manipulating the composition of the gut microbiome in the management of, or even protection from, T1DM.

摘要

引言

1型糖尿病(T1DM)是一种自身免疫性疾病。肠道微生物群被认为是T1DM发病机制中的关键因素。

目的

识别可能与T1DM相关的肠道微生物组。这可能会对未来对T1DM发病机制的理解以及预防和治疗T1DM的可能方法产生影响。

材料与方法

该研究纳入了40例T1DM患者以及一个年龄和性别匹配的20名健康受试者的交叉匹配对照组;从每组采集粪便样本。采用针对16S rRNA的定量SYBR Green实时荧光定量PCR技术对[具体微生物名称未给出]进行鉴定和定量。

结果

与对照组相比,T1DM患者的[具体微生物名称未给出]显著更高(<0.001)和[具体微生物名称未给出]更高(=0.003),但[具体微生物名称未给出]更低(=0.013)。然而,在[具体微生物名称未给出](=0.204)、[具体微生物名称未给出](=0.598)、[具体微生物名称未给出](=0.901)和[具体微生物名称未给出](=0.332)方面,T1DM患者与对照组之间无统计学差异。

结论

埃及患者表现出肠道微生物组的生态失调,这可能与T1DM的发病机制有关。这有望指出在T1DM的管理甚至预防中操纵肠道微生物组组成的潜在治疗益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/10395059/82820002c5db/PG-18-50395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/10395059/7a2d21543ed7/PG-18-50395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/10395059/82820002c5db/PG-18-50395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/10395059/7a2d21543ed7/PG-18-50395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/10395059/82820002c5db/PG-18-50395-g002.jpg

相似文献

1
Study of the gut microbiome in Egyptian patients with type 1 diabetes mellitus.埃及1型糖尿病患者肠道微生物群的研究。
Prz Gastroenterol. 2023;18(2):190-197. doi: 10.5114/pg.2023.126055. Epub 2023 Mar 22.
2
Study of the gut microbiome in Egyptian patients with Parkinson's Disease.埃及帕金森病患者肠道微生物组研究。
BMC Microbiol. 2023 Jul 22;23(1):196. doi: 10.1186/s12866-023-02933-7.
3
Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study.中国 1 型糖尿病患儿肠道菌群失调:一项观察性研究。
World J Gastroenterol. 2021 May 21;27(19):2394-2414. doi: 10.3748/wjg.v27.i19.2394.
4
Study of the gut microbiome in Egyptian patients with active ulcerative colitis.埃及活动性溃疡性结肠炎患者肠道微生物群的研究。
Rev Gastroenterol Mex (Engl Ed). 2023 Jul-Sep;88(3):246-255. doi: 10.1016/j.rgmxen.2022.07.006. Epub 2022 Jul 26.
5
Study of gut microbiome in Egyptian patients with autoimmune thyroid diseases.研究埃及自身免疫性甲状腺疾病患者的肠道微生物组。
Int J Clin Pract. 2021 May;75(5):e14038. doi: 10.1111/ijcp.14038. Epub 2021 Feb 4.
6
Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosis.埃及缓解复发型多发性硬化症患者肠道微生物组的分子特征。
Mult Scler Relat Disord. 2022 Jan;57:103354. doi: 10.1016/j.msard.2021.103354. Epub 2021 Nov 6.
7
Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans.利用源自糖尿病患者的人工合成肠道微生物组使小鼠出现肠道菌群失调、炎症和 2 型糖尿病。
Braz J Biol. 2021 Aug 6;83:e242818. doi: 10.1590/1519-6984.242818. eCollection 2021.
8
Study of the gut Microbiome Profile in Children with Autism Spectrum Disorder: a Single Tertiary Hospital Experience.孤独症谱系障碍患儿肠道微生物群特征研究:一家三级医院的单中心经验
J Mol Neurosci. 2020 Jun;70(6):887-896. doi: 10.1007/s12031-020-01500-3. Epub 2020 Feb 15.
9
Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study.地理位置对埃及1型糖尿病患儿肠道微生物群特征的影响:一项初步研究。
Int J Gen Med. 2022 Jul 15;15:6173-6187. doi: 10.2147/IJGM.S361169. eCollection 2022.
10
Adjuvant Probiotics of subsp. AP-32, MH-68, and subsp. CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus.亚亚种 AP-32、MH-68 和 CP-9 的益生菌辅助治疗可降低 1 型糖尿病患者的血糖水平和炎症细胞因子。
Front Endocrinol (Lausanne). 2022 Mar 1;13:754401. doi: 10.3389/fendo.2022.754401. eCollection 2022.

引用本文的文献

1
Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications.肠道微生物群与代谢产物:糖尿病及其并发症的生物标志物和治疗靶点
Nutrients. 2025 Aug 11;17(16):2603. doi: 10.3390/nu17162603.
2
T-Cell Receptor Sequences Identify Combined Coxsackievirus- Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus- Infections for Type 1 Diabetes.T 细胞受体序列将柯萨奇病毒联合感染鉴定为自身免疫性心肌炎的触发因素,将柯萨奇病毒感染鉴定为 1 型糖尿病的触发因素。
Int J Mol Sci. 2024 Feb 1;25(3):1797. doi: 10.3390/ijms25031797.

本文引用的文献

1
Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.肠道菌群失调在 1 型糖尿病及其相关并发症发病机制中的作用:从发病机制到靶向肠道微生物调控治疗。
Int J Mol Sci. 2021 Mar 9;22(5):2763. doi: 10.3390/ijms22052763.
2
A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.埃及 1 型和 2 型糖尿病患者肠道微生物组的比较研究。
PLoS One. 2020 Sep 9;15(9):e0238764. doi: 10.1371/journal.pone.0238764. eCollection 2020.
3
Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.
评估肠道微生物群在 1 型糖尿病中的因果作用及其可能的发病机制。
Front Endocrinol (Lausanne). 2020 Mar 24;11:125. doi: 10.3389/fendo.2020.00125. eCollection 2020.
4
Frontline Science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes.前沿科学:非肥胖型糖尿病小鼠的肠道黏膜异常先于 1 型糖尿病的发生。
J Leukoc Biol. 2019 Sep;106(3):513-529. doi: 10.1002/JLB.3HI0119-024RR. Epub 2019 Jul 16.
5
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.1 型糖尿病和 MODY2 患儿与健康对照儿童的肠道微生物群在组成和功能上存在差异:一项病例对照研究。
Diabetes Care. 2018 Nov;41(11):2385-2395. doi: 10.2337/dc18-0253. Epub 2018 Sep 17.
6
Gut microbiota profiling in Han Chinese with type 1 diabetes.汉族 1 型糖尿病患者的肠道微生物组分析。
Diabetes Res Clin Pract. 2018 Jul;141:256-263. doi: 10.1016/j.diabres.2018.04.032. Epub 2018 May 5.
7
Role of in Human Health and Diseases.(原文中“Role of in Human Health and Diseases.”缺少关键信息,无法准确翻译完整意思,仅能翻译为“……在人类健康与疾病中的作用” )
Front Microbiol. 2018 Apr 19;9:757. doi: 10.3389/fmicb.2018.00757. eCollection 2018.
8
Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes.生命早期营养因素与自身免疫性糖尿病发生发展中的黏膜免疫
Front Immunol. 2017 Sep 28;8:1219. doi: 10.3389/fimmu.2017.01219. eCollection 2017.
9
Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.口服益生菌VSL#3通过调节微生物群和促进富含吲哚胺2,3-双加氧酶的耐受性肠道环境来预防自身免疫性糖尿病。
J Diabetes Res. 2016;2016:7569431. doi: 10.1155/2016/7569431. Epub 2015 Dec 8.
10
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes.肠道微生物群的改变与1型糖尿病易感性相关。
Diabetes. 2015 Oct;64(10):3510-20. doi: 10.2337/db14-1847. Epub 2015 Jun 11.